Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese e81701

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Hsu, Wei Yi ^a,b   Chen, Chao Jung ^a,b   Huang, Yu Chuen ^a,b   Tsai, Fuu Jen ^a,c   Jeng, Long Bin ^a   Lai, Chien Chen ^b,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLADENOSINE; 2 DEOXYGUANOSINE; 3 METHYLCYTIDINE; ADENOSINE; CARCINOEMBRYONIC ANTIGEN; CYTIDINE; INOSINE; NUCLEOSIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ETHNIC GROUP; FALSE POSITIVE RESULT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID ANALYSIS; REFERENCE VALUE; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; STOMACH CANCER; TAIWANESE; TANDEM MASS SPECTROMETRY; TISSUE SPECIFICITY; URINALYSIS; URINE LEVEL;

BREAST NEOPLASMS; COLONIC NEOPLASMS; HUMANS; LUNG NEOPLASMS; NUCLEOSIDES; STOMACH NEOPLASMS; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 84893184746     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081701     Document Type: Article

References (18)

1. Davis GE, Suits RD, Kuo KC, Gehrke CW, Waalkes TP, et al. (1977) High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids. Clin chem 23: 1427-1435. (Pubitemid 8163260)
2. Struck W, Waszczuk-Jankowska M, Kaliszan R, Markuszewski MJ (2011) The state-of-the-art determination of urinary nucleosides using chromatographic techniques "hyphenated" with advanced bioinformatic methods. Anal Bioanal Chem 401: 2039-2050.
3. Struck W, Siluk D, Yumba-Mpanga A, Markuszewski M, Kaliszan R, et al. (2013) Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers. J Chromatogr A 1283: 122-131.
4. Gehrke CW, Kuo KC, Davis GE, Suits RD, Waalkes TP, et al. (1978) Quantitative high-performance liquid chromatography of nucleosides in biological materials. J Chromatogr 150: 455-476. (Pubitemid 8297831)
5. Hsu W-Y, Chen WT-L, Lin W-D, Tsai F-J, Tsai Y, et al. (2009) Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta 402: 31-37.
6. Woo HM, Kim KM, Choi MH, Jung BH, Lee J, et al. (2009) Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta 400: 63-69.
7. Li HY, Wang SM, Liu HM, Bu SS, Li J, et al. (2009) Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry. J Mass Spectrom 44: 641-651.
8. Rodriguez-Gonzalo E, Garcia-Gomez D, Carabias-Martinez R (2011) Development and validation of a hydrophilic interaction chromatography-tandem mass spectrometry method with on-line polar extraction for the analysis of urinary nucleosides. Potential application in clinical diagnosis. J Chromatogr A 1218: 9055-9063.
9. Markuszewski MJ, Struck W, Waszczuk-Jankowska M, Kaliszan R (2010) Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques. Electrophoresis 31: 2300-2310.
10. Szymanska E, Markuszewski MJ, Markuszewski M, Kaliszan R (2010) Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis. J Pharm Biomed Anal 53: 1305-1312.
11. Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S, Karihtala P (2010) 8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer. Br J Cancer 102: 1018-1023.
12. Cho SH, Choi MH, Lee WY, Chung BC (2009) Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. Clin Biochem 42: 540-543.
13. Seidel A, Brunner S, Seidel P, Fritz GI, Herbarth O (2006) Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Br J Cancer 94: 1726-1733. (Pubitemid 43924939)
14. Hsu W-Y, Lin W-D, Tsai Y, Lin C-T, Wang H-C, et al. (2011) Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta 412: 1861-1866.
15. Bartels H, Bohmer M, Heierli C (1972) Serum creatinine determination without protein precipitation. Clin Chim Acta 37: 193-197.
16. Borek E (1971) Transfer RNA and transfer RNA modification in differentiation and neoplasia. Introduction. Cancer Res 31: 596-597.
17. Borek E, Baliga BS, Gehrke CW, Kuo CW, Belman S, et al. (1977) High turnover rate of transfer RNA in tumor tissue. Cancer Res 37: 3362-3366. (Pubitemid 8169926)
18. McEntire JE, Kuo KC, Smith ME, Stalling DL, Richens JW, et al. (1989) Classification of lung cancer patients and controls by chromatography of modified nucleosides in serum. Cancer Research 49: 1057-1062. (Pubitemid 19064368)